M, K., GK, P., PJ, H., JA, L., D, C., DR, C., . . . WR, T. (2018). Germline pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines. Journal of gastrointestinal oncology, 9(3), 416. https://doi.org/10.21037/jgo.2018.02.03
Chicago Style (17th ed.) CitationM, Khushman, et al. "Germline Pharmacogenomics of DPYD*9A (c.85T>C) Variant in Patients with Gastrointestinal Malignancies Treated with Fluoropyrimidines." Journal of Gastrointestinal Oncology 9, no. 3 (2018): 416. https://doi.org/10.21037/jgo.2018.02.03.
MLA (9th ed.) CitationM, Khushman, et al. "Germline Pharmacogenomics of DPYD*9A (c.85T>C) Variant in Patients with Gastrointestinal Malignancies Treated with Fluoropyrimidines." Journal of Gastrointestinal Oncology, vol. 9, no. 3, 2018, p. 416, https://doi.org/10.21037/jgo.2018.02.03.